TipRanks
Evolutionary Genomics Inc (FNAM)
OTHER OTC:FNAM
US Market
FNAM
Evolutionary Genomics
RESEARCH TOOLSreports

Evolutionary Genomics (FNAM) Income Statement

1 Followers

Evolutionary Genomics Income Statement

Last quarter (Q4 2022), Evolutionary Genomics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Evolutionary Genomics's net income was $-254.77K. See Evolutionary Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 12.50K$ 122.69K$ 114.81K
Gross Profit
$ -1.02M$ -1.04M$ -1.78M$ -83.14K$ 114.81K
Operating Expenses
$ 992.81K$ 1.84M$ 1.10M$ 897.51K$ 951.61K
Depreciation and Amortization
$ 1.02M$ 1.04M$ 409.37K$ 40.72K$ 41.08K
EBITDA
$ -913.47K$ -1.76M$ -2.47M$ -734.10K$ -795.72K
Operating Income
$ -2.01M$ -2.88M$ -2.88M$ -774.83K$ -836.80K
Other Income/Expenses
$ 79.33K$ 84.00K$ 180.56K$ 13.59K$ -261.82K
Pretax Income
$ -1.93M$ -2.79M$ -2.70M$ -761.23K$ -1.10M
Net Income
$ -1.93M$ -2.79M$ -1.71M$ -793.14K$ -1.10M
Per Share Metrics
Basic EPS
$ -0.35$ -0.52$ -0.34$ -0.13$ -0.19
Diluted EPS
$ -0.35$ -0.52$ -0.34$ -0.13$ -0.19
Weighted Average Shares Outstanding
 6.42M 5.88M 5.88M 5.88M 5.88M
Weighted Average Shares Outstanding (Diluted)
 6.46M 5.88M 5.88M 5.88M 5.88M
Currency in USD

Evolutionary Genomics Earnings and Revenue History